Helen Susan Kim - 31 Aug 2022 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role: Director
Signature: /s/ Michael Malecek, as Attorney in Fact for Helen S. Kim
Issuer symbol: PRTA
Transactions as of: 31 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 02 Sep 2022, 21:41:27 UTC
Previous filing: 02 Sep 2022
Next filing: 19 May 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRTA	Stock Option (Right to Buy)	Award	$0	+30,000		$0.000000	30,000	31 Aug 2022	Ordinary Shares	30,000	$27.57	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option will vest and become exercisable as to 33 and 1/3% of the total number of shares subject to the option on the first anniversary of the grant date, 33 and 1/3% on the second anniversary of the grant date, and the remaining 33 and 1/3% on the earlier of the third anniversary of the grant date or the day of the annual general meeting in 2025 of the Issuer's shareholders, assuming continuous services as a director until each such vesting date.

Content

The shares subject to the option will vest and become exercisable as to 33 and 1/3% of the total number of shares subject to the option on the first anniversary of the grant date, 33 and 1/3% on the second anniversary of the grant date, and the remaining 33 and 1/3% on the earlier of the third anniversary of the grant date or the day of the annual general meeting in 2025 of the Issuer's shareholders, assuming continuous services as a director until each such vesting date.